Fitc-FF-FMK fuses a diphenylalanine motif with an FMK group and a fluorescent FITC label. The aromatic residues influence binding to hydrophobic protease pockets. Researchers employ this reagent to visualize enzyme interaction and monitor covalent inhibition. Its fluorescence enables sensitive detection of protease engagement.
CAT No: HB00022
Fitc-FF-FMK is a synthetic peptide inhibitor featuring a fluorescein isothiocyanate (FITC) label and a fluoromethyl ketone (FMK) reactive group. As a biochemically engineered molecule, it combines the sequence of two phenylalanine residues (FF) with a covalently reactive FMK moiety, enabling targeted and irreversible inhibition of protease activity. The attached FITC fluorophore facilitates direct visualization and quantification in fluorescence-based assays, making this compound highly valuable for research applications that require both specific protease targeting and sensitive detection. Fitc-FF-FMK is widely recognized for its utility in elucidating protease function, mapping enzyme localization, and monitoring proteolytic processes in a range of experimental systems.
Protease activity profiling: In biochemical research, Fitc-FF-FMK serves as a potent and selective probe for profiling the activity of serine and cysteine proteases. Its FMK group forms an irreversible covalent bond with the active site cysteine of target proteases, effectively inhibiting their catalytic function. The FITC label allows for real-time detection and quantification of enzyme-inhibitor complexes via fluorescence-based methods, providing researchers with a powerful tool to study protease activity dynamics in cell lysates, tissue extracts, or purified protein systems.
Enzyme localization studies: The fluorescent properties of Fitc-FF-FMK enable its application in imaging-based investigations of protease distribution within biological samples. By incubating cells or tissue sections with the labeled inhibitor, researchers can visualize the spatial localization of active proteases using fluorescence microscopy or confocal imaging techniques. This approach is instrumental in mapping the subcellular or tissue-specific distribution of proteolytic activity, supporting studies in cell biology, developmental biology, and disease-related protease dysregulation.
Inhibitor screening and assay development: Fitc-FF-FMK is frequently utilized in the development and validation of high-throughput screening assays for protease inhibitors. By providing a quantifiable fluorescent readout upon binding and inactivation of target enzymes, it facilitates the rapid assessment of candidate compounds for their inhibitory potency and specificity. This capability is especially valuable in early-stage drug discovery and chemical biology, where robust, sensitive, and reproducible assay platforms are essential for lead identification and optimization.
Mechanistic studies of proteolysis: The compound's ability to irreversibly inhibit specific proteases makes it a critical tool for dissecting the mechanistic details of proteolytic pathways. Researchers can employ Fitc-FF-FMK to selectively block target enzymes in complex biological mixtures and monitor downstream effects on substrate processing, signaling cascades, or cellular phenotypes. Such studies contribute to a deeper understanding of protease function in physiological and pathophysiological contexts, advancing knowledge in fields ranging from apoptosis research to extracellular matrix remodeling.
Quantitative proteomics: The dual functionality of Fitc-FF-FMK as both an inhibitor and a fluorescent tag supports its integration into quantitative proteomics workflows. By labeling active proteases in complex samples, the compound enables enrichment and subsequent identification of enzyme-inhibitor complexes using affinity purification and mass spectrometry. This approach allows for comprehensive profiling of active protease populations, facilitating biomarker discovery, comparative analyses, and the investigation of protease regulation under various experimental conditions.
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More